Metabolic Panel Differences and Applications
Panel Components and Clinical Applications
- A Comprehensive Metabolic Panel (CMP) includes all components of a Basic Metabolic Panel (BMP) plus liver function tests, while a BMP focuses only on kidney function, electrolytes, and glucose, as recommended by clinical guidelines 1, 2
- The American College of Clinical Endocrinologists recommends monitoring glucose levels using a BMP 1
- The National Comprehensive Cancer Network recommends using a CMP when comprehensive assessment of metabolic status is needed, such as in patients with tumor lysis syndrome 3, 4
- The American Society of Clinical Oncology recommends using a CMP for initial evaluation of patients with suspected liver disease and for follow-up after nephrectomy for renal cell carcinoma 4, 5
- The American Heart Association recommends using a CMP as part of obesity assessment, which includes liver function tests and other metabolic markers 1, 2
- The American Society of Hematology recommends using a CMP for evaluation of patients with acute leukemia, which requires comprehensive metabolic assessment 4
Clinical Decision-Making
- The American College of Physicians recommends ordering a CMP when liver function assessment is needed, such as in patients with right upper quadrant pain, overdose, liver disorder, malignancy, heart disease, jaundice, hepatomegaly, or ascites 1
- The National Institute of Diabetes and Digestive and Kidney Diseases recommends using a CMP for initial evaluation of patients with suspected metabolic disorders, which includes comprehensive assessment of liver function and other metabolic markers 1
Laboratory Tests for Metabolic and Lipid Assessment
Components of Metabolic and Lipid Panels
- A Comprehensive Metabolic Panel (CMP) includes 14 components measuring kidney function, electrolytes, glucose, and liver function, and does not include a lipid panel, according to the American College of Rheumatology 6
- The CMP components include electrolytes such as sodium, potassium, carbon dioxide, and chloride, as recommended by the American Diabetes Association 7
- The CMP also includes kidney function tests, such as blood urea nitrogen (BUN) and creatinine, as well as glucose and liver function tests, as specified by the American Diabetes Association 7
- A lipid panel is a separate test that measures total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, and non-HDL cholesterol, as recommended by the American College of Cardiology 7, 8
Clinical Guidelines and Recommendations
- The American Gastroenterological Association recommends ordering both a CMP and a fasting lipid profile as part of basic laboratory evaluation for obesity assessment, with a strength of evidence level of high 9
- The American Diabetes Association guidelines specify obtaining a lipid profile separately from routine metabolic panels for cardiovascular risk assessment, with a moderate level of evidence 10, 7
- The American College of Rheumatology guidelines reference CMP for metabolic monitoring but separately address lipid monitoring when clinically indicated, with a low level of evidence 11, 12
Metabolic Panel Testing Guidelines
Indications for Comprehensive Metabolic Panel (CMP)
- The National Comprehensive Cancer Network recommends ordering a CMP for initial cancer workup, including renal cell carcinoma and myeloproliferative neoplasms, as it provides comprehensive metabolic assessment including liver function 13, 14
- The American Heart Association and American Stroke Association suggest that a CMP may be ordered for acute stroke evaluation, as it includes liver function tests that can help identify underlying conditions 15
- The American Gastroenterological Association recommends NAFLD screening in high-risk patients using a CMP, which includes liver function tests such as ALT, AST, and total bilirubin 16
Indications and Monitoring Guidelines for the Basic Metabolic Panel (BMP)
BMP Indications in Specific Clinical Scenarios
- For patients with hypertension, a BMP should be obtained to assess electrolytes and kidney function after initiating or titrating antihypertensive therapy, with repeat testing recommended within 2–4 weeks. 17
- When an ACE inhibitor or ARB is started, a BMP is advised to check serum potassium and creatinine approximately 2 weeks after initiation. 17
- Patients commencing thiazide‑type diuretics (or undergoing dose escalation) should have a BMP for routine electrolyte monitoring, performed within 4 weeks of the change. 17
- In the evaluation of acute kidney injury where liver disease is not a concern, a BMP is the appropriate laboratory panel. 17
Monitoring Frequency and Follow‑up
- After any medication adjustment that may affect electrolytes or renal function, BMP re‑testing is recommended within 2–4 weeks; once laboratory values are stable, monitoring can be spaced to every 3–6 months. 17
Advanced Chronic Kidney Disease Considerations
- For patients with advanced chronic kidney disease (eGFR < 30 mL/min/1.73 m²), close BMP monitoring of electrolytes is essential because compensatory mechanisms wane and the risk of hyperkalemia rises. 17